TCW Group Inc. Has $2.85 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

TCW Group Inc. reduced its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 28.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 44,963 shares of the company's stock after selling 17,925 shares during the quarter. TCW Group Inc.'s holdings in Acadia Healthcare were worth $2,851,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Acadia Healthcare during the 2nd quarter worth about $59,000. Covestor Ltd raised its position in shares of Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the third quarter valued at about $86,000.

Acadia Healthcare Trading Up 0.8 %

NASDAQ:ACHC traded up $0.32 during mid-day trading on Friday, hitting $40.66. The company had a trading volume of 1,084,705 shares, compared to its average volume of 1,039,865. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The firm has a market cap of $3.78 billion, a P/E ratio of 13.33, a P/E/G ratio of 1.77 and a beta of 1.29. The business's fifty day moving average is $45.39 and its two-hundred day moving average is $61.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the firm earned $0.91 EPS. Acadia Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. Cantor Fitzgerald restated a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday. Royal Bank of Canada lowered their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and raised their price target for the company from $45.00 to $75.00 in a report on Thursday. Finally, Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $75.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.